Cargando…
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213359/ https://www.ncbi.nlm.nih.gov/pubmed/34179831 http://dx.doi.org/10.1016/S2665-9913(21)00181-8 |
| _version_ | 1783709829808783360 |
|---|---|
| author | Boekel, Laura Kummer, Laura Y van Dam, Koos P J Hooijberg, Femke van Kempen, Zoé Vogelzang, Erik H Wieske, Luuk Eftimov, Filip van Vollenhoven, Ronald Kuijpers, Taco W van Ham, S Marieke Tas, Sander W Killestein, Joep Boers, Maarten Nurmohamed, Mike T Rispens, Theo Wolbink, Gertjan |
| author_facet | Boekel, Laura Kummer, Laura Y van Dam, Koos P J Hooijberg, Femke van Kempen, Zoé Vogelzang, Erik H Wieske, Luuk Eftimov, Filip van Vollenhoven, Ronald Kuijpers, Taco W van Ham, S Marieke Tas, Sander W Killestein, Joep Boers, Maarten Nurmohamed, Mike T Rispens, Theo Wolbink, Gertjan |
| author_sort | Boekel, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8213359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82133592021-06-21 Adverse events after first COVID-19 vaccination in patients with autoimmune diseases Boekel, Laura Kummer, Laura Y van Dam, Koos P J Hooijberg, Femke van Kempen, Zoé Vogelzang, Erik H Wieske, Luuk Eftimov, Filip van Vollenhoven, Ronald Kuijpers, Taco W van Ham, S Marieke Tas, Sander W Killestein, Joep Boers, Maarten Nurmohamed, Mike T Rispens, Theo Wolbink, Gertjan Lancet Rheumatol Comment Elsevier Ltd. 2021-08 2021-06-18 /pmc/articles/PMC8213359/ /pubmed/34179831 http://dx.doi.org/10.1016/S2665-9913(21)00181-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Boekel, Laura Kummer, Laura Y van Dam, Koos P J Hooijberg, Femke van Kempen, Zoé Vogelzang, Erik H Wieske, Luuk Eftimov, Filip van Vollenhoven, Ronald Kuijpers, Taco W van Ham, S Marieke Tas, Sander W Killestein, Joep Boers, Maarten Nurmohamed, Mike T Rispens, Theo Wolbink, Gertjan Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title_full | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title_fullStr | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title_full_unstemmed | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title_short | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases |
| title_sort | adverse events after first covid-19 vaccination in patients with autoimmune diseases |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213359/ https://www.ncbi.nlm.nih.gov/pubmed/34179831 http://dx.doi.org/10.1016/S2665-9913(21)00181-8 |
| work_keys_str_mv | AT boekellaura adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT kummerlauray adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT vandamkoospj adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT hooijbergfemke adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT vankempenzoe adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT vogelzangerikh adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT wieskeluuk adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT eftimovfilip adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT vanvollenhovenronald adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT kuijperstacow adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT vanhamsmarieke adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT tassanderw adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT killesteinjoep adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT boersmaarten adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT nurmohamedmiket adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT rispenstheo adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases AT wolbinkgertjan adverseeventsafterfirstcovid19vaccinationinpatientswithautoimmunediseases |